Previous close | 37.10 |
Open | 40.90 |
Bid | 35.70 |
Ask | 43.90 |
Strike | 200.00 |
Expiry date | 2025-06-20 |
Day's range | 40.90 - 40.90 |
Contract range | N/A |
Volume | |
Open interest | 28 |
Biogen ( NASDAQ:BIIB ) First Quarter 2024 Results Key Financial Results Revenue: US$2.29b (down 7.0% from 1Q 2023). Net...
It's been a good week for Biogen Inc. ( NASDAQ:BIIB ) shareholders, because the company has just released its latest...
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.